CRM
MJN

Cramer Rosenthal McGlynn’s Mead Johnson Nutrition Company MJN Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-98,955
Closed -$7M – 237
2016
Q4 		$7M Buy
+98,955
New +$7.37M 0.1% 169

Other funds holding MJN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $20.5B AUM 26.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cramer Rosenthal McGlynn's MJN Position: Q1 2017 in Review

Cramer Rosenthal McGlynn sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 98,955 shares — an estimated $7M sold.

Cramer Rosenthal McGlynn first reported a position in MJN in Q4 2016 and held it in 1 quarter. The position peaked at $7M in Q4 2016. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

  • Cramer Rosenthal McGlynn reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 98,955 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $7M.
  • Cramer Rosenthal McGlynn first reported a position in Mead Johnson Nutrition Company in Q4 2016 and held it in 1 quarter.
  • Cramer Rosenthal McGlynn's Mead Johnson Nutrition Company position peaked at $7M in Q4 2016.
  • 533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Cramer Rosenthal McGlynn's 13F filing for Q1 2017, filed 12 May 2017.